MiR-17-5p inhibits cerebral hypoxia/reoxygenationinjury by targeting PTEN through regulation of PI3K/AKT/mTOR signaling pathway

被引:10
|
作者
Ren, Xiang [1 ]
Jing, Ying-Xia [2 ]
Zhou, Zhi-Wen [1 ]
Yang, Qi-Ming [1 ]
机构
[1] Hunan Normal Univ, Affiliated Hosp 1, Hunan Prov Peoples Hosp, Dept Neurol, 569 Wangjiali Rd, Changsha 410016, Peoples R China
[2] Hunan Normal Univ, Affiliated Hosp 1, Hunan Prov Peoples Hosp, Dept Emergency, Changsha, Peoples R China
关键词
MiR-17-5p; cerebral ischemia-reperfusion; apoptosis; PTEN; PI3K; AKT; mTOR signalling pathway; ISCHEMIA-REPERFUSION INJURY; MICRORNAS; PROTECTS; CANCER;
D O I
10.1080/00207454.2020.1806836
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Objective To investigate the role and mechanism of miR-17-5p in cerebral hypoxia/reoxygenation (H/R)-induced apoptosis. Methods The present study used human brain microvascular endothelial cells (HBMVECs) to establish cerebral H/R model. MTT was used to measure the cell viability. Flow cytometry was used to detect the cell apoptosis. The interaction between miR-17-5p and PTEN was determined using dual luciferase reporter assay. RT-qPCR and Western blotting were used for determination of the expression of miR-17-5p, PTEN, apoptosis- and PI3K/AKT/mTOR signalling-related proteins. Results The cell viability and the expression of miR-17-5p were obviously down-regulated while the expression of PTEN was obviously up-regulated in H/R cells. The cell viability was remarkably enhanced, and the cell apoptosis induced by H/R injury was dramatically reduced when miR-17-5p was overexpressed in HBMVECs under H/R condition, which was reversed by overexpression of PTEN. Dual luciferase reporter assay showed PTEN was a direct target of miR-17-5p. Treatment of PI3K inhibitor LY294002 significantly increased the apoptosis rate of HBMVECs, and this effect was significantly reversed by transfection of miR-17-5p mimics, while further dramatically enhanced by overexpression of PTEN. Conclusion MiR-17-5p could ameliorate cerebral I/R injury-induced cell apoptosis by directly targeting PTEN and regulation of PI3K/AKT/mTOR signalling.
引用
收藏
页码:192 / 200
页数:9
相关论文
共 50 条
  • [31] Targeting the PI3K/Akt/mTOR Pathway in Ocular Neovascularization
    Sasore, Temitope
    Reynolds, Alison L.
    Kennedy, Breandan N.
    RETINAL DEGENERATIVE DISEASES: MECHANISMS AND EXPERIMENTAL THERAPY, 2014, 801 : 805 - 811
  • [32] MiR-150-5p contributes to unexplained recurrent spontaneous abortion by targeting VEGFA and downregulating the PI3K/AKT/mTOR signaling pathway
    Wenyan Liao
    Xin Deng
    Guodong Chen
    Juanli Yang
    Yi Li
    Li Li
    Lili Zhong
    Guangwei Tao
    Jiafeng Hou
    Mujun Li
    Chengming Ding
    Journal of Assisted Reproduction and Genetics, 2024, 41 : 63 - 77
  • [33] PirB inhibits axonal outgrowth via the PI3K/Akt/mTOR signaling pathway
    Bi, Yong-Yan
    Quan, Yong
    MOLECULAR MEDICINE REPORTS, 2018, 17 (01) : 1093 - 1098
  • [34] Targeting the PI3K/Akt/mTOR Pathway - Beyond Rapalogs
    Markman, Ben
    Dienstmann, Rodrigo
    Tabernero, Josep
    ONCOTARGET, 2010, 1 (07) : 530 - 543
  • [35] The PI3K/AKT/MTOR signaling pathway: The role of PI3K and AKT inhibitors in breast cancer
    Huemer F.
    Bartsch R.
    Gnant M.
    Current Breast Cancer Reports, 2014, 6 (2) : 59 - 70
  • [36] MiR-150-5p contributes to unexplained recurrent spontaneous abortion by targeting VEGFA and downregulating the PI3K/AKT/mTOR signaling pathway
    Liao, Wenyan
    Deng, Xin
    Chen, Guodong
    Yang, Juanli
    Li, Yi
    Li, Li
    Zhong, Lili
    Tao, Guangwei
    Hou, Jiafeng
    Li, Mujun
    Ding, Chengming
    JOURNAL OF ASSISTED REPRODUCTION AND GENETICS, 2024, 41 (01) : 63 - 77
  • [37] Loss of PTEN expression in patients treated with PI3K/AKT/mTOR signaling pathway inhibitors
    Janku, Filip
    Garrido-Laguna, Ignacio
    Tsimberidou, Apostolia M.
    Naing, Aung
    Fu, Siqing
    Falchook, Gerald S.
    Abraham, Susan C.
    Hong, David S.
    Kurzrock, Razelle
    CANCER RESEARCH, 2011, 71
  • [38] Targeting the mTOR/AKT/PI3K pathway in paediatric malignancies
    Pearson, A.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S74 - S74
  • [39] Targeting the PI3K/Akt/mTOR pathway in hepatocellular carcinoma
    Zhou, Qian
    Lui, Vivian W. Y.
    Yeo, Winnie
    FUTURE ONCOLOGY, 2011, 7 (10) : 1149 - 1167
  • [40] Targeting the PI3K/Akt/mTOR Pathway in Hepatocellular Carcinoma
    Sun, Eun Jin
    Wankell, Miriam
    Palamuthusingam, Pranavan
    McFarlane, Craig
    Hebbard, Lionel
    BIOMEDICINES, 2021, 9 (11)